Saint Louis, Missouri-based Emerson Electric Co. (EMR) is a technology and software company that provides various solutions in the Americas and internationally. Valued at a market cap of $84.7 billion, the company operates through Final Control, Measurement & Analytical, Discrete Automation, Safety & Productivity, Control Systems & Software, and Test & Measurement segments.

Companies with a market capitalization of $10 billion or more are typically referred to as "large-cap stocks." EMR fits right into that category, with its market cap exceeding this threshold, reflecting its substantial size and influence in the industrials industry.

Nvidia Stock May Be Oversold - What is the Best NVDA Play?

Jobs, Geopolitics and Other Key Things to Watch this Week

As Coinbase Rolls out 24/5 Stock Trading, Should You Snap up COIN?

Get exclusive insights with the FREE Barchart Brief newsletter. Subscribe now for quick, incisive midday market analysis you won't find anywhere else.

Emerson touched its 52-week high of $165.15 on Feb. 11, and is down 8.7% from that peak. Over the past three months, the stock surged 14.7%, underperforming the State Street Industrial Select Sector SPDR ETF’s (XLI) 15.9% surge during the same time frame.

Over the past 52 weeks, the industrial company’s shares surged 25.6%, trailing behind XLI, which delivered a stronger 31.7% returns over the same time frame. On the other hand, EMR has been trading above its 200-day moving average since last year and above its 50-day moving average since the start of January.

On Feb. 3, EMR shares grew 2.3% following the release of its Q4 2025 earnings. The company’s revenue amounted to $4.4 billion and matched the Street’s estimates. Moreover, its adjusted EPS for the quarter came in at $1.46, topping Wall Street estimates successfully. The company expects full-year earnings in the range of $6.40 to $6.55 per share.

When stacked against its closest peer in the industrial space, Eaton Corporation plc (ETN) has climbed 29.5% over the past year, outperforming EMR.

Nevertheless, sentiment on EMR remains somewhat optimistic. Among the 25 analysts covering the stock, the consensus rating is a “Moderate Buy.” Its mean price target of $168.25 suggests 11.6% upside potential from current price levels.

On the date of publication, Anushka Mukherjee did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Barchart.com